Blueprint Medicines Corporation Asset Turnover Ratio (BPMC), as of first quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Blueprint Medicines Corporation  (NASDAQ: BPMC)
 

Blueprint Medicines Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Blueprint Medicines Corporation asset turnover ratio, the ability of Blueprint Medicines Corporation's assets to generate revenue in the first quarter 2025, increased sequentially to 0.49 in the first quarter (Mar 31 2025), yet the ratio remained below the average, as BPMC's position remain challenging.

Within sector 67 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2025, to 1797, from total ranking in the fourth quarter 2024 at 2118.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BPMC Asset Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Asset Change 24.64 % 14.24 % 9.96 % 9.89 % -15.65 %
Y / Y Revenue Change 55.45 % 88.19 % 126.61 % 139.98 % 67.25 %
Asset Turnover Ratio (TTM) 0.49 0.47 0.42 0.36 0.29
BPMC's Total Ranking # 1797 # 2118 # 1827 # 1729 # 423
Seq. Asset Change 8.13 % -1.62 % -0.24 % 17.44 % -0.89 %
Seq. Revenue Change 2.08 % 14.19 % -7.22 % 43.74 % 23.58 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 206
Overall Market # 1797

Asset Turnover Ratio Statistics
High Average Low
92.28 13.53 -125.4
(Dec 31 2019)   (Jun 30 2019)




BPMC Company Profile • Back to BPMC Efficiency Comparisons • Compare BPMC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Assets at quarter ending Mar 31 2025
Indivior Pharmaceuticals Inc   1.29 $ 2,059.000  Millions$ 1,600.750  Millions
Koru Medical Systems Inc   1.29 $ 35.084  Millions$ 27.282  Millions
Electrocore Inc   1.28 $ 25.660  Millions$ 19.978  Millions
Xtant Medical Holdings Inc   1.27 $ 122.157  Millions$ 96.033  Millions
Aveanna Healthcare Holdings Inc   1.26 $ 2,093.077  Millions$ 1,658.191  Millions
Exagen Inc   1.26 $ 55.820  Millions$ 44.474  Millions
Ardent Health Inc   1.25 $ 6,024.260  Millions$ 4,819.015  Millions
Henry Schein Inc   1.22 $ 12,669.000  Millions$ 10,388.500  Millions
Sunshine Biopharma Inc   1.22 $ 36.235  Millions$ 29.776  Millions
Warby Parker Inc   1.21 $ 794.355  Millions$ 653.860  Millions
Hca Healthcare Inc   1.21 $ 71,585.000  Millions$ 59,037.250  Millions
Evolus Inc   1.21 $ 274.596  Millions$ 227.328  Millions
Avadel Pharmaceuticals Plc  1.20 $ 194.118  Millions$ 161.990  Millions
Electromed Inc   1.19 $ 60.984  Millions$ 51.459  Millions
Idexx Laboratories Inc  1.18 $ 3,931.236  Millions$ 3,318.191  Millions
Nuo Therapeutics Inc   1.18 $ 1.615  Millions$ 1.369  Millions
Mettler toledo International Inc   1.17 $ 3,830.156  Millions$ 3,260.918  Millions
Nuwellis Inc   1.17 $ 8.709  Millions$ 7.447  Millions
Precipio inc   1.16 $ 20.029  Millions$ 17.263  Millions
Pro dex Inc   1.15 $ 64.124  Millions$ 55.884  Millions
Cytomx Therapeutics Inc   1.14 $ 147.557  Millions$ 129.308  Millions
Vaso Corporation  1.14 $ 87.491  Millions$ 76.715  Millions
Dynatronics Corporation  1.13 $ 28.427  Millions$ 25.055  Millions
Natera Inc   1.13 $ 1,831.000  Millions$ 1,625.259  Millions
Trisalus Life Sciences Inc   1.12 $ 31.543  Millions$ 28.126  Millions
Phibro Animal Health Corporation  1.12 $ 1,190.083  Millions$ 1,061.979  Millions
The Pennant Group Inc   1.12 $ 748.167  Millions$ 668.093  Millions
Inogen Inc   1.11 $ 339.960  Millions$ 304.922  Millions
Puma Biotechnology Inc   1.11 $ 232.709  Millions$ 208.809  Millions
Docgo Inc   1.11 $ 520.501  Millions$ 467.116  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.